Paul E. Mallet, Ph.D. - Publications

1991 Psychology University of Windsor, Windsor, Canada 
 1991-1997 Psychology Queen's University at Kingston, Kingston, Ontario, Canada 
 1997-1999 Psychology University of Sydney, Camperdown, New South Wales, Australia 
 1999-2005 School of Psychology University of New England, Armidale 
 2006- Psychology Wilfrid Laurier, Waterloo, Ontario, Canada 
learning and memory, addiction, cannabinoids

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Miladinovic T, Manwell LA, Raaphorst E, Malecki SL, Rana SA, Mallet PE. Effects of chronic nicotine exposure on Δ-tetrahydrocannabinol-induced locomotor activity and neural activation in male and female adolescent and adult rats. Pharmacology, Biochemistry, and Behavior. 172931. PMID 32353393 DOI: 10.1016/j.pbb.2020.172931  1
2019 Manwell LA, Miladinovic T, Raaphorst E, Rana S, Malecki S, Mallet PE. Chronic nicotine exposure attenuates the effects of Δ -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats. Brain and Behavior. e01375. PMID 31583843 DOI: 10.1002/Brb3.1375  1
2015 Manwell LA, Mallet PE. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. Psychopharmacology. 232: 1655-65. PMID 25395060 DOI: 10.1007/s00213-014-3798-5  1
2015 Rojo M, Claud C, Mallet PE, Noer G, Carleton AM, Vicomte M. Polar low tracks over the Nordic Seas: A 14-winter climatic analysis Tellus, Series a: Dynamic Meteorology and Oceanography. 67. DOI: 10.3402/Tellusa.V67.24660  1
2014 Manwell LA, Charchoglyan A, Brewer D, Matthews BA, Heipel H, Mallet PE. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents. Journal of Pharmacological and Toxicological Methods. 70: 120-7. PMID 24973534 DOI: 10.1016/j.vascn.2014.06.006  1
2014 Manwell LA, Ford B, Matthews BA, Heipel H, Mallet PE. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents. Journal of Pharmacological and Toxicological Methods. 70: 112-9. PMID 24956154 DOI: 10.1016/J.Vascn.2014.06.004  1
2013 Mallet PE, Claud C, Cassou C, Noer G, Kodera K. Polar lows over the nordic and labrador seas: Synoptic circulation patterns and associations with north atlantic-europe wintertime weather regimes Journal of Geophysical Research: Atmospheres. 118: 2455-2472. DOI: 10.1002/jgrd.50246  1
2012 Perit KE, Gmaz JM, Caleb Browne JD, Matthews BA, Dunn MB, Yang L, Raaphorst T, Mallet PE, McKay BE. Distribution of c-Fos immunoreactivity in the rat brain following abuse-like toluene vapor inhalation. Neurotoxicology and Teratology. 34: 37-46. PMID 22074881 DOI: 10.1016/J.Ntt.2011.10.007  1
2010 Hanstock TL, Mallet PE, Clayton EH. Increased plasma d-lactic acid associated with impaired memory in rats. Physiology & Behavior. 101: 653-9. PMID 20888356 DOI: 10.1016/j.physbeh.2010.09.018  1
2010 Rana SA, Mallet PE, Robertson BA, Wainwright PE. Effect of complete maternal and littermate deprivation on morphine-induced Fos-immunoreactivity in the adult male rat brain. Pediatric Research. 67: 263-7. PMID 19915516 DOI: 10.1203/Pdr.0B013E3181Ca0807  1
2009 Verty AN, Boon WM, Mallet PE, McGregor IS, Oldfield BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16. PMID 19490094 DOI: 10.1111/j.1460-9568.2009.06750.x  1
2009 Mallet PE, Moore CA, Collie MT, Satvat E. Regional distribution of Ginkgo biloba-induced c-Fos immunoreactivity. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 16: 361-8. PMID 18757190 DOI: 10.1016/J.Phymed.2008.07.007  1
2009 Satvat E, Mallet PE. Chronic administration of a Ginkgo biloba leaf extract facilitates acquisition but not performance of a working memory task. Psychopharmacology. 202: 173-85. PMID 18594796 DOI: 10.1007/S00213-008-1223-7  1
2008 Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1113-26. PMID 17581536 DOI: 10.1038/sj.npp.1301475  1
2006 O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology (Oxford, England). 20: 611-21. PMID 16714325 DOI: 10.1177/0269881106065188  1
2006 Gardner A, Mallet PE. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'. European Journal of Pharmacology. 530: 103-6. PMID 16380113 DOI: 10.1016/J.Ejphar.2005.11.032  1
2006 Singh ME, McGregor IS, Mallet PE. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 58-69. PMID 15920503 DOI: 10.1038/Sj.Npp.1300770  1
2005 Young JM, McGregor IS, Mallet PE. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1475-82. PMID 16178074 DOI: 10.1038/Sj.Npp.1300692  1
2005 O'Shea M, Mallet PE. Impaired learning in adulthood following neonatal delta9-THC exposure. Behavioural Pharmacology. 16: 455-61. PMID 16148451 DOI: 10.1097/00008877-200509000-00019  1
2005 Singh ME, McGregor IS, Mallet PE. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology. 49: 1189-200. PMID 16137723 DOI: 10.1016/J.Neuropharm.2005.07.008  1
2005 Verty AN, McGregor IS, Mallet PE. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9. PMID 16098995 DOI: 10.1016/J.Neuropharm.2005.03.025  1
2005 McGregor IS, Dam KD, Mallet PE, Gallate JE. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 35-45. PMID 15550450 DOI: 10.1093/Alcalc/Agh113  1
2004 O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology (Oxford, England). 18: 502-8. PMID 15582916 DOI: 10.1177/0269881104047277  1
2004 Singh ME, Verty AN, Price I, McGregor IS, Mallet PE. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69. PMID 15567425 DOI: 10.1016/J.Neuropharm.2004.08.008  1
2004 Singh ME, Verty AN, McGregor IS, Mallet PE. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research. 1026: 244-53. PMID 15488486 DOI: 10.1016/J.Brainres.2004.08.027  1
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 47: 593-603. PMID 15380376 DOI: 10.1016/J.Neuropharm.2004.06.002  1
2004 Verty AN, McGregor IS, Mallet PE. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Research. 1020: 188-95. PMID 15312802 DOI: 10.1016/J.Brainres.2004.06.033  1
2004 Hanstock TL, Clayton EH, Li KM, Mallet PE. Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of rats. Physiology & Behavior. 82: 357-68. PMID 15276799 DOI: 10.1016/J.Physbeh.2004.04.002  1
2004 Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. Neuropharmacology. 46: 954-65. PMID 15081792 DOI: 10.1016/J.Neuropharm.2004.01.002  1
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology. 145: 3224-31. PMID 15033920 DOI: 10.1210/En.2004-0059  1
2004 Verty AN, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354: 217-20. PMID 14700735 DOI: 10.1016/J.Neulet.2003.10.035  1
2004 Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology. 173: 210-6. PMID 14663553 DOI: 10.1007/S00213-003-1694-5  1
2003 Verty AN, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168: 314-23. PMID 12700881 DOI: 10.1007/S00213-003-1451-9  1
2003 Norwood CS, Cornish JL, Mallet PE, McGregor IS. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. European Journal of Pharmacology. 465: 105-14. PMID 12650839 DOI: 10.1016/S0014-2999(03)01455-9  1
2003 Allen KV, McGregor IS, Hunt GE, Singh ME, Mallet PE. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. Neuropharmacology. 44: 264-74. PMID 12623225 DOI: 10.1016/S0028-3908(02)00364-7  1
2001 Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology. 433: 91-9. PMID 11755138 DOI: 10.1016/S0014-2999(01)01512-6  1
2001 Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Research. 921: 240-55. PMID 11720732 DOI: 10.1016/S0006-8993(01)03127-4  1
1999 Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology. 370: 233-40. PMID 10334497 DOI: 10.1016/S0014-2999(99)00170-3  1
1999 Mason KI, Mallet PE, Jhamandas K, Boegman RJ, Beninger RJ. Nucleus basalis injections of N-methyl-D-aspartate enhance memory of rats in the double Y-maze. Brain Research Bulletin. 48: 65-71. PMID 10210169 DOI: 10.1016/S0361-9230(98)00146-4  1
1998 Mallet PE, Beninger RJ. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology. 140: 11-9. PMID 9862397 DOI: 10.1007/S002130050733  1
1998 Mallet PE, Beninger RJ. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sciences. 62: 2431-9. PMID 9651110 DOI: 10.1016/S0024-3205(98)00226-4  1
1998 Abrahams BS, Rutherford JD, Mallet PE, Beninger RJ. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. European Journal of Pharmacology. 343: 111-8. PMID 9570457 DOI: 10.1016/S0014-2999(97)01531-8  1
1996 Mallet PE, Beninger RJ. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats Behavioural Pharmacology. 7: 276-284. DOI: 10.1097/00008877-199605000-00008  1
1995 Mallet PE, Beninger RJ, Flesher SN, Jhamandas K, Boegman RJ. Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory. Brain Research Bulletin. 36: 51-6. PMID 7882049 DOI: 10.1016/0361-9230(94)00162-T  1
1995 Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats. Pharmacology, Biochemistry, and Behavior. 51: 739-46. PMID 7675853 DOI: 10.1016/0091-3057(95)00024-Q  1
1994 Smith CG, Beninger RJ, Mallet PE, Jhamandas K, Boegman RJ. Basal forebrain injections of the benzodiazepine partial inverse agonist FG 7142 enhance memory of rats in the double Y-maze. Brain Research. 666: 61-7. PMID 7889368 DOI: 10.1016/0006-8993(94)90282-8  1
1994 Mallet PE, Beninger RJ. 7-OH-DPAT produces place conditioning in rats. European Journal of Pharmacology. 261: R5-6. PMID 7813542 DOI: 10.1016/0014-2999(94)90127-9  1
1993 Cohen JS, Mallet PE, O'Malley K. Chunking by Proximal Arm Cues Facilitates Rats′ Performance in the Radial Maze Learning and Motivation. 24: 413-432. DOI: 10.1006/lmot.1993.1023  1
1989 Mallet PE. Le choix d'un lait infantile en 1989 Journal De Pediatrie Et De Puericulture. 2: 227-228.  1
Show low-probability matches.